2 results
Approved WMOCompleted
The Purpose of the study is to investigate the clinical feasibility of the TW15 and TW22.
Approved WMOCompleted
To demonstrate the superiority of the combination Nebivolol plus HCTZ versus Irbesartan plus HCTZ in terms of SBP reduction after 12 weeks of treatment in elderly patients with isolated systolic hypertension.